abstract |
The present invention relates to 1H-quinazolin-2,4-dione of formula I, wherein R 1 and R 2 are as defined herein, methods for their preparation, their use as AMPA-receptor ligands, in particular epilepsy or schizophrenia Use for the treatment of, and pharmaceutical compositions containing the same. Also described are intermediates for the preparation of compounds of formula (I) and combinations comprising compounds of formula (I).n n n <Formula I> |